Health Care & Life Sciences » Pharmaceuticals | Celltrion Pharm Inc.

Celltrion Pharm Inc. | Mutual Funds

Mutual Funds that own Celltrion Pharm Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
246,520
0.72%
6,437
0.01%
07/31/2018
Government Pension Fund - Global (The)
141,840
0.42%
141,840
0%
12/31/2017
iShares MSCI South Korea Capped ETF
113,990
0.34%
0
0.21%
09/06/2018
Vanguard Developed Markets Index Fund
97,035
0.28%
0
0.01%
07/31/2018
iShares MSCI Emerging Markets ETF
91,795
0.27%
0
0.02%
09/06/2018
DFA Emerging Markets Small Cap Series
78,722
0.23%
-1
0.08%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
60,461
0.18%
0
0.02%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
41,699
0.12%
0
0.04%
07/31/2018
Mirae Asset TIGER Health Care ETF
31,944
0.09%
8,256
1.54%
04/30/2018
Vanguard Investment Series Plc - Emerging Markets Stock Index
28,452
0.08%
28,452
0.02%
07/31/2018

About Celltrion Pharm

View Profile
Address
82 2sandan-ro
Cheongju-si NC 28117
Korea, Republic Of
Employees -
Website http://www.celltrionph.com
Updated 09/14/2018
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs.